Literature DB >> 11463352

Increase in class 2 aldehyde dehydrogenase expression by arachidonic acid in rat hepatoma cells.

R A Canuto1, M Ferro, R A Salvo, A M Bassi, A Trombetta, M Maggiora, G Martinasso, R Lindahl, G Muzio.   

Abstract

Aldehyde dehydrogenase (ALDH) is a family of several isoenzymes important in cell defence against both exogenous and endogenous aldehydes. Compared with normal hepatocytes, in rat hepatoma cells the following changes in the expression of ALDH occur: cytosolic class 3 ALDH expression appears and mitochondrial class 2 ALDH decreases. In parallel with these changes, a decrease in the polyunsaturated fatty acid content in membrane phospholipids occurs. In the present study we demonstrated that restoring the levels of arachidonic acid in 7777 and JM2 rat hepatoma cell lines to those seen in hepatocytes decreases hepatoma cell growth, and increases class 2 ALDH activity. This latter effect appears to be due to an increased gene transcription of class 2 ALDH. To account for this increase, we examined whether peroxisome-proliferator-activated receptors (PPARs) or lipid peroxidation were involved. We demonstrated a stimulation of PPAR expression, which is different in the two hepatoma cell lines: in the 7777 cell line, there was an increase in PPAR alpha expression, whereas PPAR gamma expression increased in JM2 cells. We also found increased lipid peroxidation, but this increase became evident at a later stage when class 2 ALDH expression had already increased. In conclusion, arachidonic acid added to the culture medium of hepatoma cell lines is able to partially restore the normal phenotype of class 2 ALDH, in addition to a decrease in cell growth.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11463352      PMCID: PMC1222011          DOI: 10.1042/0264-6021:3570811

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  47 in total

Review 1.  Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators.

Authors:  J C Corton; S P Anderson; A Stauber
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

2.  Peroxisome proliferator activated receptor-gamma (PPAR-gamma) mediates the action of gamma linolenic acid in breast cancer cells.

Authors:  W G Jiang; A Redfern; R P Bryce; R E Mansel
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2000-02       Impact factor: 4.006

3.  Two aldehyde dehydrogenases from human liver. Isolation via affinity chromatography and characterization of the isozymes.

Authors:  N J Greenfield; R Pietruszko
Journal:  Biochim Biophys Acta       Date:  1977-07-08

4.  The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis.

Authors:  G Leonarduzzi; A Scavazza; F Biasi; E Chiarpotto; S Camandola; S Vogel; R Dargel; G Poli
Journal:  FASEB J       Date:  1997-09       Impact factor: 5.191

5.  Oxazaphosphorine-specific resistance in human MCF-7 breast carcinoma cell lines expressing transfected rat class 3 aldehyde dehydrogenase.

Authors:  K D Bunting; R Lindahl; A J Townsend
Journal:  J Biol Chem       Date:  1994-09-16       Impact factor: 5.157

6.  Genotyping of alcohol dehydrogenase at the ADH2 and ADH3 loci by using a polymerase chain reaction and restriction-fragment-length polymorphism in Chinese alcoholic cirrhotics and non-alcoholics.

Authors:  Y C Chao; M F Wang; H S Tang; C T Hsu; S J Yin
Journal:  Proc Natl Sci Counc Repub China B       Date:  1994-07

7.  Inhibition of c-myc expression induced by 4-hydroxynonenal, a product of lipid peroxidation, in the HL-60 human leukemic cell line.

Authors:  G Barrera; R Muraca; S Pizzimenti; A Serra; C Rosso; G Saglio; M G Farace; V M Fazio; M U Dianzani
Journal:  Biochem Biophys Res Commun       Date:  1994-08-30       Impact factor: 3.575

8.  Local application of gamma-linolenic acid in the treatment of human gliomas.

Authors:  U N Das; V V Prasad; D R Reddy
Journal:  Cancer Lett       Date:  1995-08-01       Impact factor: 8.679

9.  The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs.

Authors:  I Issemann; R A Prince; J D Tugwood; S Green
Journal:  J Mol Endocrinol       Date:  1993-08       Impact factor: 5.098

10.  Enrichment with arachidonic acid increases the sensitivity of hepatoma cells to the cytotoxic effects of oxidative stress.

Authors:  R A Canuto; G Muzio; A M Bassi; M Maggiora; G Leonarduzzi; R Lindahl; M U Dianzani; M Ferro
Journal:  Free Radic Biol Med       Date:  1995-02       Impact factor: 7.376

View more
  5 in total

1.  Hepatocyte nuclear factor-4 alpha mediates the stimulatory effect of peroxisome proliferator-activated receptor gamma co-activator-1 alpha (PGC-1 alpha) on glucose-6-phosphatase catalytic subunit gene transcription in H4IIE cells.

Authors:  Jared N Boustead; Beth T Stadelmaier; Angela M Eeds; Peter O Wiebe; Christina A Svitek; James K Oeser; Richard M O'Brien
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

2.  Involvement of PPARs in Cell Proliferation and Apoptosis in Human Colon Cancer Specimens and in Normal and Cancer Cell Lines.

Authors:  G Martinasso; M Oraldi; A Trombetta; M Maggiora; O Bertetto; R A Canuto; G Muzio
Journal:  PPAR Res       Date:  2007       Impact factor: 4.964

3.  Differential gene expression profiles of gastric cancer cells established from primary tumour and malignant ascites.

Authors:  C Sakakura; A Hagiwara; M Nakanishi; K Shimomura; T Takagi; R Yasuoka; Y Fujita; T Abe; Y Ichikawa; S Takahashi; T Ishikawa; I Nishizuka; T Morita; H Shimada; Y Okazaki; Y Hayashizaki; H Yamagishi
Journal:  Br J Cancer       Date:  2002-11-04       Impact factor: 7.640

Review 4.  Mitochondrial Dysfunction in Cancer and Neurodegenerative Diseases: Spotlight on Fatty Acid Oxidation and Lipoperoxidation Products.

Authors:  Giuseppina Barrera; Fabrizio Gentile; Stefania Pizzimenti; Rosa Angela Canuto; Martina Daga; Alessia Arcaro; Giovanni Paolo Cetrangolo; Alessio Lepore; Carlo Ferretti; Chiara Dianzani; Giuliana Muzio
Journal:  Antioxidants (Basel)       Date:  2016-02-19

5.  Genetic variants of ALDH2-rs671 and CYP2E1-rs2031920 contributed to risk of hepatocellular carcinoma susceptibility in a Chinese population.

Authors:  Xinping Ye; Xiangkun Wang; Liming Shang; Guangzhi Zhu; Hao Su; Chuangye Han; Wei Qin; Guanghui Li; Tao Peng
Journal:  Cancer Manag Res       Date:  2018-05-04       Impact factor: 3.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.